Suntrust Banks Inc. decreased its holdings in shares of Fresenius Medical Care Corporation (NYSE:FMS) by 1.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 24,934 shares of the company’s stock after selling 307 shares during the quarter. Suntrust Banks Inc.’s holdings in Fresenius Medical Care Corporation were worth $1,204,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. UBS Asset Management Americas Inc. boosted its holdings in Fresenius Medical Care Corporation by 3.6% in the second quarter. UBS Asset Management Americas Inc. now owns 2,357 shares of the company’s stock valued at $114,000 after purchasing an additional 81 shares in the last quarter. Pacer Advisors Inc. purchased a new position in Fresenius Medical Care Corporation in the second quarter valued at approximately $179,000. FFT Wealth Management LLC purchased a new position in Fresenius Medical Care Corporation in the second quarter valued at approximately $201,000. HPM Partners LLC purchased a new position in Fresenius Medical Care Corporation in the second quarter valued at approximately $221,000. Finally, GHP Investment Advisors Inc. purchased a new position in Fresenius Medical Care Corporation in the second quarter valued at approximately $224,000. Hedge funds and other institutional investors own 2.61% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/04/fresenius-medical-care-corporation-fms-position-trimmed-by-suntrust-banks-inc.html.

Fresenius Medical Care Corporation (NYSE FMS) opened at 49.72 on Wednesday. The firm has a market cap of $30.51 billion, a price-to-earnings ratio of 21.34 and a beta of 0.48. Fresenius Medical Care Corporation has a 52-week low of $38.05 and a 52-week high of $50.22. The firm’s 50-day moving average price is $47.80 and its 200 day moving average price is $46.49.

Fresenius Medical Care Corporation (NYSE:FMS) last posted its quarterly earnings results on Tuesday, August 1st. The company reported $0.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.53 by ($0.05). Fresenius Medical Care Corporation had a net margin of 7.06% and a return on equity of 11.57%. The company had revenue of $4.47 billion during the quarter, compared to analyst estimates of $5.20 billion. During the same period in the prior year, the company earned $0.96 earnings per share. The company’s revenue was up 11.1% on a year-over-year basis. On average, equities research analysts forecast that Fresenius Medical Care Corporation will post $2.34 EPS for the current year.

A number of analysts have weighed in on FMS shares. Zacks Investment Research cut shares of Fresenius Medical Care Corporation from a “hold” rating to a “sell” rating in a report on Tuesday. Royal Bank Of Canada restated a “hold” rating and issued a $44.00 target price on shares of Fresenius Medical Care Corporation in a report on Wednesday, September 13th. DZ Bank AG restated a “buy” rating on shares of Fresenius Medical Care Corporation in a report on Monday, August 7th. BidaskClub downgraded shares of Fresenius Medical Care Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Finally, UBS AG reaffirmed a “sell” rating on shares of Fresenius Medical Care Corporation in a research report on Tuesday, July 4th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company. Fresenius Medical Care Corporation currently has a consensus rating of “Hold” and an average target price of $48.67.

Fresenius Medical Care Corporation Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Institutional Ownership by Quarter for Fresenius Medical Care Corporation (NYSE:FMS)

Receive News & Stock Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related stocks with our FREE daily email newsletter.